APA

Henry K., Katzenstein D., Cherng D. W., Valdez H., Powderly W., Vargas M. B., Jahed N. C., Jacobson J. M., Myers L. S., Schmitz J. L., Winters M. & Tebas P. (20060711). A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102. : Journal of acquired immune deficiency syndromes (1999).

Chicago

Henry Keith, Katzenstein David, Cherng Deborah Weng, Valdez Hernan, Powderly William, Vargas Michelle Blanchard, Jahed Nasreen C, Jacobson Jeffrey M, Myers Laurie S, Schmitz John L, Winters Mark and Tebas Pablo. 20060711. A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102. : Journal of acquired immune deficiency syndromes (1999).

Harvard

Henry K., Katzenstein D., Cherng D. W., Valdez H., Powderly W., Vargas M. B., Jahed N. C., Jacobson J. M., Myers L. S., Schmitz J. L., Winters M. and Tebas P. (20060711). A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102. : Journal of acquired immune deficiency syndromes (1999).

MLA

Henry Keith, Katzenstein David, Cherng Deborah Weng, Valdez Hernan, Powderly William, Vargas Michelle Blanchard, Jahed Nasreen C, Jacobson Jeffrey M, Myers Laurie S, Schmitz John L, Winters Mark and Tebas Pablo. A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102. : Journal of acquired immune deficiency syndromes (1999). 20060711.